Obido, Alfredo, Jr. E.
HRN: 09-45-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/14/2025
02/21/2025
IV
300mg
Q6H
Peritonsillar Abscess, Right
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes